facebook

Helixate® FS, Antihemophilic Factor (Recombinant), Will No Longer Be Manufactured After December 2017

We recognize Helixate FS has been an important part of your hemophilia A treatment. After supplying Helixate FS for more than two decades, it was with a great deal of consideration that the decision was made to phase out this product. Helixate FS will no longer be manufactured after December 2017.

  • We anticipate that some supply will remain available through early 2019
  • CSL Behring will continue to provide updates regarding the remaining Helixate FS supply. Sign up to receive this information via email
link to other Factor VIII Information

Helixate FS: Availability and What Comes Next

We’ve created an FAQ to answer questions you may have

Download the FAQ Carbiners

CSL Behring offers a next-generation treatment option for hemophilia A

At CSL Behring, we listen to and address the needs of those who rely on our treatment therapies. The hemophilia community deserves innovative therapies built for today. With that in mind, we’ve put our resources into developing a next-generation therapy to help continue your Factor VIII treatment—AFSTYLA.

AFSTYLA is the first and only recombinant Factor VIII that delivers proven, long-lasting bleed protection with a novel single-chain design. Please take a moment to explore all that AFSTYLA can offer you, starting with twice-weekly dosing.*

*FDA approved for dosing 2 to 3 times a week.

There are many benefits to staying with CSL Behring and choosing AFSTYLA

Familiar reconstitution and transfer system

AFSTYLA uses the same Mix2Vial® needle-free reconstitution and transfer system that you are familiar and comfortable with using.

Support programs

All the support services you have come to rely on and trust with Helixate FS are available with AFSTYLA. Services include:

  • CSL Behring AssuranceSM Program—helps make treatment available in case of a lapse in insurance coverage
    • Any Assurance points you have already earned will automatically transfer to your AFSTYLA balance
  • My Access®—the co-pay program that provides up to $12,000 of annual out-of-pocket expenses associated with therapy
  • CSL Behring Patient Assistance ProgramSM—helps people who are uninsured or underinsured

Ask your My SourceSM Care Coordinator for details about these programs, to check your transferred Assurance points balance, or any other questions you may have.

Contact My Source at 1-800-676-4266, Monday through Friday, 8 am to 8 pm ET.

Terms and conditions apply.

Get updates on Helixate FS and learn about AFSTYLA

Stay up to date

Sign up for the latest information on Helixate FS and AFSTYLA.

  • Check the appropriate box to indicate that you currently take Helixate FS so we can update you with the latest information about availability
  • Request your free AFSTYLA Discovery Kit to get everything you need to learn more about AFSTYLA delivered right to your door

Is AFSTYLA right for you?

Choose one of the two options below to download the Doctor Discussion Guide that best fits you. Then talk with your doctor at the next appointment.

I am a...

— OR —

Ready to get started with AFSTYLA? Try a free 30-day trial

Before visiting your doctor, print out this form and bring it to your appointment to request a 30-day free trial of AFSTYLA. All insured patients are eligible, including those covered by Medicare and Medicaid.

Terms and conditions apply.
Questions?
Call My Source
1-800-676-4266

Monday through Friday, 8 am to 8 pm ET

Your doctor, specialty pharmacy, or CSL Behring Representative can also help answer questions you may have about Helixate FS or AFSTYLA

You are now leaving the current website.

Do you want to continue?

No Yes